Biogen Reports Early Success from Apellis Acquisition
Since Biogen’s acquisition of Apellis in May 2026, the company’s C3 complement therapies, Syfovre® and Empaveli®, have generated a combined $128 million in revenues.
Nia Therapeutics Develops Breakthrough Device to Restore Memory
The device is based on technology developed at Penn by Dr. Kahana and Dr. Rizzuto.
Kira Pharmaceuticals to Merge with Jasper Therapeutics in a Deal Backed by $132M to Advance Immune Disease Pipeline
Jasper Therapeutics recently completed its merger with Kira Pharmaceuticals.
New mRNA Vaccine Could Reduce the Recurrence and Spread of Skin Cancer
Moderna and Merck announced a successful late-stage trial for a personalized mRNA vaccine designed to help prevent the return and spread of melanoma.
Pennovation Accelerator’s Pitch Day 2025
The Pennovation Accelerator held its eighth annual Pitch Day on July 23, 2025, the final event for the cohort's six-week program focused on business development.
Penn Robotics Technology Spotlight
These technologies focus on developing innovative solutions to improve healthcare, engineering, and everyday life.
Penn Vet & Animal Health Technology Spotlight
Penn's technology portfolio includes cutting-edge inventions from Penn Vet.
Nuclear Medicine Symposium Highlights Innovation Opportunities
The program at uCity Square featured panel discussions on this key emerging area of Philadelphia’s economy.
Penn AI Technologies are Making an Impact in the Medical Imaging Space
In radiology, Penn researchers are using AI to support with more efficient medical imaging processes.
Penn Dental’s Henry Daniell Develops Chewing Gum to Fight Viruses and Microbes
The special chewing gum is made from the lablab bean and is designed to neutralize disease-causing pathogens present in the mouth.